Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

REmission in Rheumatoid Arthritis - Assessing WIthrawal of Disease-modifying Antirheumatic Drugs in a Non-inferiority Design

NCT01881308 is registered in ClinicalTrials.gov with Diakonhjemmet Hospital as lead sponsor.

NCT NCT01881308
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01881308 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
REmission in Rheumatoid Arthritis - Assessing WIthrawal of Disease-modifying Antirheumatic Drugs in a Non-inferiority Design
Lead sponsor
Diakonhjemmet Hospital
Phase
Phase 4
Overall status
Completed
Start date
June 17, 2013
Completion date
January 31, 2022
Enrollment
320 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis